| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.03 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.03 |